Latest Articles

Publication Date
Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN - Dove Medical Press

Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN Dove Medical Press

Published: Feb. 2, 2026, 7:47 a.m.
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - The Manila Times

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress The Manila Times

Published: Jan. 23, 2026, 1:20 p.m.
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - manilatimes.net

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress manilatimes.net

Published: Jan. 23, 2026, 1:20 p.m.
‘The Moral Property of Women’: Mifepristone as Contraception. Who Gets to Decide? - Ms. Magazine

‘The Moral Property of Women’: Mifepristone as Contraception. Who Gets to Decide? Ms. Magazine

Published: Jan. 22, 2026, 12:02 p.m.
New oral contrast agent helps spot 'previously impossible-to-detect' findings on CT - Radiology Business

New oral contrast agent helps spot 'previously impossible-to-detect' findings on CT Radiology Business

Published: Jan. 21, 2026, 10:16 p.m.
‘The Moral Property of Women’: Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere - Ms. Magazine

‘The Moral Property of Women’: Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere Ms. Magazine

Published: Jan. 21, 2026, 12:05 p.m.
'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science - Ms. Magazine

'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science Ms. Magazine

Published: Jan. 20, 2026, 12:05 p.m.
Oral-B iO Series 5 deal: $99.99 at Amazon - Mashable

Oral-B iO Series 5 deal: $99.99 at Amazon Mashable

Published: Jan. 16, 2026, 2:12 a.m.
FOGSI Consensus Redefines Endometriosis Care with Oral GnRH Antagonist, Elagolix - Medical Dialogues

FOGSI Consensus Redefines Endometriosis Care with Oral GnRH Antagonist, Elagolix Medical Dialogues

Published: Jan. 2, 2026, 6:13 a.m.
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors - The Manila Times

Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors The Manila Times

Published: Oct. 24, 2025, 3:57 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!